Two Dimensions in Targeting HER2

被引：22
作者：
Moasser, Mark M. [1 ]
机构：
[1] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 19期
基金：
美国国家卫生研究院;
关键词：
METASTATIC BREAST-CANCER; TYROSINE KINASE INHIBITOR; PHASE-II TRIAL; TRASTUZUMAB HERCEPTIN; MONOCLONAL-ANTIBODY; PHOSPHATIDYLINOSITOL; 3-KINASE; ADJUVANT CHEMOTHERAPY; LAPATINIB MONOTHERAPY; EXPRESSION LEVEL; CELL-LINES;
D O I：
10.1200/JCO.2014.55.7652
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2074 / U125
页数：5
相关论文
共 72 条
  • [1] Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth
    Agus, DB
    Akita, RW
    Fox, WD
    Lewis, GD
    Higgins, B
    Pisacane, PI
    Lofgren, JA
    Tindell, C
    Evans, DP
    Maiese, K
    Scher, HI
    Sliwkowski, MX
    [J]. CANCER CELL, 2002, 2 (02) : 127 - 137
  • [2] Resiliency and Vulnerability in the HER2-HER3 Tumorigenic Driver
    Amin, Dhara N.
    Sergina, Natalia
    Ahuja, Deepika
    McMahon, Martin
    Blair, Jimmy A.
    Wang, Donghui
    Hann, Byron
    Koch, Kevin M.
    Shokat, Kevan M.
    Moasser, Mark M.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2010, 2 (16) : 16ra7
  • [3] [Anonymous], J CLIN ONCOL S
  • [4] Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism?
    Arnould, L
    Gelly, M
    Penault-Llorca, F
    Benoit, L
    Bonnetain, F
    Migeon, C
    Cabaret, V
    Fermeaux, V
    Bertheau, P
    Garnier, J
    Jeannin, JF
    Coudert, B
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (02) : 259 - 267
  • [5] Bang YJ, 2010, LANCET, V376, P1302
  • [6] Baselga J, 1999, SEMIN ONCOL, V26, P78
  • [7] Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
    Baselga, Jose
    Cortes, Javier
    Kim, Sung-Bae
    Im, Seock-Ah
    Hegg, Roberto
    Im, Young-Hyuck
    Roman, Laslo
    Pedrini, Jose Luiz
    Pienkowski, Tadeusz
    Knott, Adam
    Clark, Emma
    Benyunes, Mark C.
    Ross, Graham
    Swain, Sandra M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (02) : 109 - 119
  • [8] Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy
    Baselga, Jose
    Gelmon, Karen A.
    Verma, Shailendra
    Wardley, Andrew
    Conte, PierFranco
    Miles, David
    Bianchi, Giulia
    Cortes, Javier
    McNally, Virginia A.
    Ross, Graham A.
    Fumoleau, Pierre
    Gianni, Luca
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) : 1138 - 1144
  • [9] Correlation between NK function and response to trastuzumab in metastatic breast cancer patients
    Beano, Alessandra
    Signorino, Elena
    Evangelista, Andrea
    Brusa, Davide
    Mistrangelo, Marinella
    Polimeni, Maria Antonia
    Spadi, Rosella
    Donadio, Michela
    Ciuffreda, Libero
    Matera, Lina
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2008, 6 (1)
  • [10] The Impact of HER2/neu Expression Level on Response to the E75 Vaccine: From US Military Cancer Institute Clinical Trials Group Study I-01 and I-02
    Benavides, Linda C.
    Gates, Jeremy D.
    Carmichael, Mark G.
    Patel, Ritesh
    Holmes, Jarrod P.
    Hueman, Matthew T.
    Mittendorf, Elizabeth A.
    Craig, Dianna
    Stojadinovic, Alexander
    Ponniah, Sathibalan
    Peoples, George E.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (08) : 2895 - 2904
12345678